Comparison of the heart and estrogen/progestin replacement study (HERS) cohort with women with coronary disease from the National Health and Nutrition Examination Survey III (NHANES III)

American Heart Journal

Volumn 136, Issue 1, 1998, Pages 115-124

  Herrington, D M ^a   Fong, J ^a   Sempos, C T ^a   Black, D M ^a   Schrott, H G ^a   Rautaharju, P ^a   Bachorik, P S ^a   Blumenthal, R ^a   Khan, S ^a   Wenger, N K ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN; GLUCOSE; TRIACYLGLYCEROL;

AGED; ARTICLE; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ELECTROCARDIOGRAM; FEMALE; HEALTH SURVEY; HORMONE SUBSTITUTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR;

EID: 0031821042     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(98)70191-7     Document Type: Article

References (49)

1. D Grady SM Rubin DB Petitti Hormone therapy to prevent disease and prolong life in postmenopausal women Ann Intern Med 1992 1016 1037
2. TL. Bush The epidemiology of cardiovascular disease in postmenopausal women Ann NY Acad Sci 592 1990 263 271
3. JW Rich-Edwards JE Manson CH Hennekens JE. Buring The primary prevention of coronary heart disease in women N Engl J Med 332 1995 1758 1766
4. TL. Bush Noncontraceptive estrogen use and risk of cardiovascular disease: an overview and critique of the literature SG Korenman The Menopause. Biological and clinical consequences of ovarian failure: evaluation and management. 1970 Serono Symposia Norwell (MA) 211 223
5. MJ Stampfer GA. Colditz Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence Prev Med 20 1991 47 63
6. MD Gerhard P. Ganz How do we explain the clinical benefits of estrogen? Circulation 92 1995 5 8
7. JM. Sullivan Estrogen replacement Circulation 94 1996 2699 2702
8. DM. Herrington Effects of estrogen on the anatomic and functional sequelae of coronary atherosclerosis T Forte Hormonal, metabolic, and cellular influences on cardiovascular diseases in women. 1997 Futura Armonk (NY) 175 192
9. D Grady W Applegate T Bush C Furberg B Riggs S Hulley for the HERS Study Group The Heart and Estrogen/Progestin Replacement Study: design, methods and baseline characteristics Control Clin Trials 1998 In press
10. TM Ezzati JT Massey J Waksberg A Chu KR. Maurer Sample design: Third National Health and Nutrition Examination Survey Vital Health Stat 2 1992 1 35
11. CL Johnson BM Rifkind CT Sempos Declining serum total cholesterol levels among US adults. The National Health and Nutrition Examination Surveys JAMA 269 1993 3002 3008
12. Plan and operation. Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures Vital Health Stat 1 1994 1 407
13. GA Rose H Blackburn RF Gillum RJ. Prineas Cardiovascular survey methods 1982 World Health Organization Geneva
14. ED Frohlich C Grim DR Labarthe MH Maxwell D Perloff WH. Weidman Recommendations for human blood pressure determination by sphygmomanometers Hypertension 11 1988 210A 222A
15. SM McKinlay DJ Brambilla JG. Posner The normal menopause transition Maturitas 14 1992 103 115
16. AZ LaCroix JM Guralnik JD Curb RB Wallace AM Ostfeld CH. Hennekens Chest pain and coronary heart disease mortality among older men and women in three communities Circulation 81 1990 437 446
17. PM Rautaharju PJ MacInnis JW Warren HK Wolf PM Rykers HP. Calhoun Methodology of ECG interpretation in the Dalhousie Program: NOVACODE ECG classification procedures for clinical trials and population health surveys Meth Inform Med 29 1990 362 374
18. PM Rautaharju HP Calhoun BR. Chaitman NOVACODE serial ECG classification system for clinical trials and epidemiological studies J Electrocardiol 24 1992 179 187
19. H Blackburn A Keys E Simonson PM Rautaharju S. Punsar The electrocardiogram in population studies: a classification system Circulation 21 1960 1160 1175
20. GL Myers GR Cooper CL Winn SJ. Smith The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program. An approach to accurate and precise lipid measurements J Clin Lab Med 9 1989 105 135
21. CC Allain LS Poon CS Chan W Richard PC. Fu Enzymatic determination of total serum cholesterol Clin Chem 20 1974 470 475
22. PS Bachorik RE Walker DG. Virgil High-density-lipoprotein cholesterol in heparin-Mn-C12 supernates determined with the Dow enzymic method after precipitation of Mn2+ with HCO3- Clin Chem 30 1984 839 842
23. WT Friedewald RI Levy DS. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
24. NCEP, Adult treatment panel II Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults Circulation 89 1994 1333 1445
25. GW Snedecor WG. Cochran Statistical methods 1980 Iowa State University Press Ames
26. BV Shah BG Barnell PN. Hunt SUDAAN users manual, Release 6.30 1991 Research Triangle Institute Research Triangle Park (NC)
27. P Smith H. Arnesen Mortality in non-consenters in a post-myocardial infarction trial J Intern Med 228 1990 253 256
28. L Wilhelmsen S Ljungberg H Wedel L. Werko A comparison between participants and non-participants in a primary preventive trial J Chron Dis 29 1976 331 339
29. TR. Pedersen The Norwegian Multicenter Study of timolol after myocardial infarction Circulation 67 1983 I49 I53
30. CASS Coronary Artery Surgery Study. A randomized trial of coronary artery bypass surgery. Comparability of entry charactristics and survival in randomized patients and nonrandomized patients meeting randomization criteria J Am Coll Cardiol 3 1984 114 129
31. V Fuster AM Gotto P Libby J Loscalzo HC. McGill 27th Bethesda Conference: matching the intensity of risk factor management with the hazard for coronary disease events. Task Force 1. Pathogenesis of coronary disease: the biologic role of risk factors J Am Coll Cardiol 27 1996 964 976
32. SC Smith SN Blair MH Criqui Preventing heart attack and death in patients with coronary disease Circulation 92 1995 2 4
33. JC. LaRosa Triglycerides and coronary risk in women and the elderly Arch Intern Med 157 1997 961 968
34. BW Walsh I Schiff B Rosner L Greenberg V Ravnikar FM. Sacks Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins N Engl J Med 325 1991 1196 1204
35. F Grodstein MJ Stampfer GA Colditz WC Willett JE Manson M Joffe Postmenopausal hormone therapy and mortality N Engl J Med 336 1997 1769 1775
36. Scandinavian Simvastatin Survival Study Group Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
37. FM Sacks MA Pfeffer LA Moye JL Rouleau JD Rutherford TG Cole The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators N Engl J Med 335 1996 1001 1009
38. KM Hussain L Gould B Sosler T Bharathan CV. Reddy Current aspects of thrombolytic therapy in women with acute myocardial infarction Angiology 47 1996 23 33
39. ISIS-3, Third International Study of Infarct Survival Collaborative Group A randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41,299 cases of suspected acute myocardial infarction Lancet 339 1992 753 770
40. European Coronary Surgery Study Group Long-term results of prospective randomized study of coronary artery bypass surgery in stable angina pectoris Lancet 2 1982 1173 1180
41. KM Detre P Peduzzi KE Hammermeister ML Murphy HN Hultgren T. Takaro Five-year effect of medical and surgical therapy on resting LV function in stable angina. V.A. Cooperative study Am J Cardiol 53 1984 444 450
42. CASS A randomized trial of coronary artery bypass surgery. Survival data Circulation 68 1983 939 950
43. PM. Rautaharju Use and abuse of electrocardiographic classification systems in epidemiologic studies Eur J Cardiol 8 1978 155 171
44. DA Weiner TJ Ryan CH McCabe Exercise stress testing. Correlations among history of angina, ST-segment response and prevalence of coronary artery disease in the Coronary Artery Surgery Study (CASS) N Engl J Med 301 1979 230 235
45. WB Kannel P Sorlie PM. McNamara Prognosis after initial myocardial infarction: the Framingham study Am J Cardiol 44 1979 53 59
46. GH Tofler PH Stone JE Muller Effects of gender and race on prognosis after myocardial infarction: adverse prognosis for women, particularly black women J Am Coll Cardiol 9 1987 473 482
47. JW Kennedy T Killip LD Fisher EL Alderman MJ Gillespie MB. Mock The clinical spectrum of coronary artery disease and its surgical and medical management, 1974-1979. The Coronary Artery Surgery study Circulation 66 1982 16 23
48. DJ Lerner WB. Kannel Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population Am Heart J 111 1986 383 390
49. WB Kannel M. Feinleib Natural history of angina pectoris in the Framingham study. Prognosis and survival Am J Cardiol 29 1972 154 163